Stocks-HAE-Haemonetics Corp.

HAE Haemonetics Corp.

0 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/3/2023: Haemonetics Corp.'s revenues increased by 17.67% and amounted to 1.17B. Net income increased by 166.05% to 115.40M. Net assets increased by 9.15% to 818.00M and EPS increased from 0.84 to 2.24.
HAE's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
50.85%
Net Profit Margin
7.36%
Operating Margin
15.29%
Return On Investment
5.91%